Trials / Completed
CompletedNCT00944398
Impact of Targeted Zinc Fortification Programs on Plasma Zinc Concentration
Evaluation of the Use of Plasma Zinc Concentration for Assessing the Impact of Targeted and Mass Zinc Fortification Programs
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 98 (actual)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- All
- Age
- 12 Months – 17 Months
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate the use of plasma zinc concentration for assessing the impact of targeted zinc fortification programs.
Detailed description
The objectives of the present study are to determine whether plasma zinc concentration changes in response to additional zinc consumption, as provided by zinc-fortified cereal-based complementary foods fed to young children. The following specific steps will be completed: 1. Zinc-fortified complementary foods and breads prepared from zinc-fortified cereal flours will be developed with assistance from experts in food technology. 2. A two-week feeding trial will be implemented to assess the change in plasma zinc concentration among young children who receive: a) the zinc-fortified cereal porridge and a liquid vitamin preparation between meals; b) a non-zinc-fortified cereal porridge and a liquid vitamin preparation between meals \[negative control group\]; or c) a non-zinc-fortified cereal porridge and a zinc-containing liquid vitamin preparation between meals \[positive control group\].
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Zinc fortified food | Daily consumption |
| DIETARY_SUPPLEMENT | Zinc supplement | Liquid supplement containing zinc sulfate |
| OTHER | Placebo supplement | Liquid placebo supplement |
| DIETARY_SUPPLEMENT | Non-fortified food | Non-fortified complementary food. |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-09-01
- Completion
- 2009-10-01
- First posted
- 2009-07-23
- Last updated
- 2010-02-19
Locations
1 site across 1 country: Senegal
Source: ClinicalTrials.gov record NCT00944398. Inclusion in this directory is not an endorsement.